2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow relacorilant: new trials by email Literature Review of relacorilant trials Research Report on relacorilant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas Relacorilant, Placebo - Hypercortisolism | Phase 3 | Completed | Corcept Therapeutics | 137 | 2020-07-27 | 2025-09-04 |
| A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome Relacorilant, Placebo - Cushing Syndrome | Phase 3 | Completed | Corcept Therapeutics | 152 | 2018-11-15 | 2025-07-16 |
ACTH Syndrome, Ectopic (2) · Cushing Syndrome (2) · Diabetes Mellitus, Type 2 (2) · Hypertension (2) · Pituitary ACTH Hypersecretion (1)
Austria (2) · Bulgaria (2) · Germany (2) · Israel (2) · Italy (2) · Poland (2) · Romania (2) · Spain (2) · United States (2) · Canada (1) · Netherlands (1)